Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Krogulski Kenneth
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Jones James
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Galante Joseph C
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Young Caroline
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Brown Martin S JR
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer KAZIMI A J
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Herman James L
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bitterman Chris T.
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Anthony Todd M.
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Hamm John M.
Cumberland Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-A.J. Kazimi(40.14%)
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Jones James
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Young Caroline
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Krogulski Kenneth
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer KAZIMI A J
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Hamm John M.
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Young Caroline
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Jones James
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer KAZIMI A J
Cumberland Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Krogulski Kenneth
No Data